December 11th, 2017
jobs
homes

Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

ANI Pharmaceuticals, Inc. - Common Stock (NQ:ANIP)

82.29 +0.61 (+0.75%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 15, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 284,518
Open 82.16
Bid (Size) 82.20 (200)
Ask (Size) 82.32 (300)
Prev. Close 81.68
Today's Range 81.25 - 82.99
52wk Range 62.14 - 99.50
Shares Outstanding 24,422,240
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
2 Cash-Producing Stocks to Research Further and 1 Facing Challenges
Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it eff... 
Via StockStory
News headline image
Ani (ANIP) Q1 2026 Earnings Call Transcript ↗
Ani (ANIP) Q1 2026 Earnings Call Transcript 
Via The Motley Fool
Topics Earnings

Performance

YTD
+4.9%
+4.9%
1 Month
+5.5%
+5.5%
3 Month
+14.0%
+14.0%
6 Month
+1.0%
+1.0%
1 Year
+28.0%
+28.0%

More News

Read More
News headline image
2 Growth Stocks with Explosive Upside and 1 We Avoid
Via StockStory
ANI Pharmaceuticals (NASDAQ:ANIP) Crushes Q1 Estimates, Raises Full-Year Guidance ↗
Via Chartmill
News headline image
Q1 Earnings Outperformers: ANI Pharmaceuticals (NASDAQ:ANIP) And The Rest Of The Pharmaceuticals Stocks
Via StockStory
Topics Artificial Intelligence Intellectual Property
News headline image
2 Profitable Stocks with Competitive Advantages and 1 Facing Headwinds
Via StockStory
News headline image
Global Alpha Dumps 229,000 Ani Pharmaceuticals (ANIP) Shares Worth $17.9 Million ↗
Via The Motley Fool
News headline image
ANI Pharmaceuticals Q1 Earnings Call Highlights ↗
Via MarketBeat
Topics Earnings Intellectual Property
News headline image
ANI Pharmaceuticals (NASDAQ:ANIP) Delivers Impressive Q1 CY2026, Stock Soars
Via StockStory
News headline image
ANI Pharmaceuticals (ANIP) Q1 Earnings: What To Expect
Via StockStory
Topics Artificial Intelligence
News headline image
Unpacking Q4 Earnings: Jazz Pharmaceuticals (NASDAQ:JAZZ) In The Context Of Other Pharmaceuticals Stocks
Via StockStory
Topics Artificial Intelligence Intellectual Property
News headline image
Winners And Losers Of Q4: Elanco (NYSE:ELAN) Vs The Rest Of The Pharmaceuticals Stocks
Via StockStory
Topics Artificial Intelligence Intellectual Property
News headline image
1 Cash-Producing Stock with Promising Prospects and 2 Facing Challenges
Via StockStory
Topics Economy
News headline image
1 Small-Cap Stock for Long-Term Investors and 2 We Turn Down
Via StockStory
News headline image
Artivion, ANI Pharmaceuticals, and Privia Health Shares Are Soaring, What You Need To Know
Via StockStory
News headline image
3 Russell 2000 Stocks We Steer Clear Of
Via StockStory
News headline image
ANI Pharma Insider Sells 4,772 Shares as Revenue Hits $883 Million in 2025 ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
3 Reasons ANIP is Risky and 1 Stock to Buy Instead
Via StockStory
Topics Supply Chain
News headline image
2 of Wall Street’s Favorite Stocks Worth Your Attention and 1 We Question
Via StockStory
News headline image
Pharmaceuticals Stocks Q4 Highlights: Ocular Therapeutix (NASDAQ:OCUL)
Via StockStory
Topics Artificial Intelligence Intellectual Property
News headline image
3 Profitable Stocks That Concern Us
Via StockStory
News headline image
Q4 Earnings Roundup: Amneal (NASDAQ:AMRX) And The Rest Of The Generic Pharmaceuticals Segment
Via StockStory
Topics Artificial Intelligence Intellectual Property
News headline image
Generic Pharmaceuticals Q4 Earnings: ANI Pharmaceuticals (NASDAQ:ANIP) Simply the Best
Via StockStory
Topics Artificial Intelligence Intellectual Property
News headline image
Clover Health, Alignment Healthcare, Solventum, ANI Pharmaceuticals, and Guardant Health Shares Plummet, What You Need To Know
Via StockStory
Topics Economy Stocks
News headline image
ANI Pharma (ANIP) Q4 2025 Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings

Frequently Asked Questions

Is ANI Pharmaceuticals, Inc. - Common Stock publicly traded?
Yes, ANI Pharmaceuticals, Inc. - Common Stock is publicly traded.
What exchange does ANI Pharmaceuticals, Inc. - Common Stock trade on?
ANI Pharmaceuticals, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for ANI Pharmaceuticals, Inc. - Common Stock?
The ticker symbol for ANI Pharmaceuticals, Inc. - Common Stock is ANIP on the Nasdaq Stock Market
What is the current price of ANI Pharmaceuticals, Inc. - Common Stock?
The current price of ANI Pharmaceuticals, Inc. - Common Stock is 82.29
When was ANI Pharmaceuticals, Inc. - Common Stock last traded?
The last trade of ANI Pharmaceuticals, Inc. - Common Stock was at 06/15/26 04:00 PM ET
What is the market capitalization of ANI Pharmaceuticals, Inc. - Common Stock?
The market capitalization of ANI Pharmaceuticals, Inc. - Common Stock is 2.01B
How many shares of ANI Pharmaceuticals, Inc. - Common Stock are outstanding?
ANI Pharmaceuticals, Inc. - Common Stock has 2B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

More ways to get to us

Lethbridge Herald Facebook Facebook
Lethbridge Herald Twitter Twitter
Lethbridge Herald YouTube YouTube

About Us

Contact the Lethbridge Herald

504 - 7th Street South
Lethbridge, AB T1J 3Z7

[P] (403) 328-4411
[F] (403)328-4536

Print Advertising: (403) 328-4410
National Advertising: (403) 380-7585
Online Advertising: (403) 380-7585
Classifieds: (403) 328-4433

© 1996-2017 The Lethbridge Herald, A Division of Continental Newspapers Canada Ltd.